{
  "id": "pvdl1",
  "display_name": "Peripheral vasodilators, exclude dipyridamole (SHHS1)",
  "description": "Patient taking PERIPHERAL VASODILATORS, EXCLUDE DIPYRIDAMOLE within two weeks of the SHHS1 visit.  All medications were recorded during the interview, and medication information was later categorized by physician review.",
  "type": "choices",
  "domain": "yesnof",
  "labels": [
    "PVDL1"
  ],
  "hybrid": {
    "VARNUM": "188",
    "TABLE": "SHHS1",
    "LABEL": "MU Peripheral vasodilators, exclude dipyridamole",
    "access level": "0",
    "SOURCE": "Medication Form (SHHS1)",
    "MEMNAME": "shhs1_1",
    "most commonly used": null,
    "filename": "SHHS1 Medications.pdf",
    "PARENT TERM": null
  }
}
